NASDAQ$BTMD
biote Corp · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
Reported solid revenue growth and continued progress optimizing capital structure.
Biote reported a 19.1% increase in revenue, reaching $49.3 million, driven by procedure and dietary supplement revenue growth. The company's gross profit margin increased by 60 basis points to 67.9%. Net loss was $(13.1) million, with a GAAP loss per share of $(0.25). Adjusted EBITDA increased by 10.6% to $14.5 million.
- Revenue increased by 19.1% to $49.3 million.
- Gross profit margin increased by 60 basis points to 67.9%.
- Net loss was $(13.1) million, with a GAAP loss per share of $(0.25).
- Adjusted EBITDA increased by 10.6% to $14.5 million.
Headline financials
Revenue & EPS history
biote · Revenue · Quarterly
$49.3M
Forward guidance
Biote anticipates a more moderate pace of growth in the second half of 2023 due to temporary inefficiencies from sales realignment and evolving market dynamics. As a result, the company forecasts 2023 revenue and Adjusted EBITDA will likely be toward the lower end of their guidance range.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q2 2023
-2.4%
Avg return
Earnings day
-4.0%
Avg return
5 days after
-3.0%
Avg return
30 days after
55%
11 / 20 earnings
Positive
+16.9%
Q3 2024
Best reaction
-25.1%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.9% | -9.6% | +4.6% | |
| Q4 2025 | -10.5% | -20.9% | -7.6% | |
| Q3 2025 | -2.4% | -11.1% | -13.0% | |
| Q1 2025 | +11.3% | +17.1% | +14.7% | |
| Q4 2024 | -25.1% | -0.7% | -11.0% | |
| Q3 2024 | +16.9% | -6.3% | +13.7% | |
| Q2 2024 | -21.2% | -17.8% | -10.6% | |
| Q1 2024 | +0.2% | +1.0% | +11.1% | |
| Q4 2023 | +11.9% | +27.0% | +10.1% | |
| Q3 2023 | -20.2% | -18.4% | -0.9% | |
| Q2 2023 | -14.4% | -22.0% | -23.7% | |
| Q1 2023 | -17.2% | -14.3% | -20.6% | |
| Q4 2022 | +16.6% | +34.9% | +33.3% | |
| Q3 2022 | +2.3% | +2.5% | +7.2% | |
| Q2 2022 | +1.1% | -4.6% | -7.4% | |
| Q1 2022 | +0.6% | -36.9% | -64.3% | |
| Q4 2021 | +0.0% | +0.0% | +0.6% | |
| Q3 2021 | -0.1% | +0.1% | +1.0% | |
| Q2 2021 | +0.0% | -0.5% | -0.2% | |
| Q1 2021 | +0.6% | +0.6% | +3.0% | |
| Q4 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro